Acquirer
Pfizer Inc
Pfizer Inc appears as the named buyer in 4 recorded transactions between 2016 and 2023, most often in healthcare & life sciences.
Record
What Pfizer Inc has bought
Every recorded transaction where Pfizer Inc is the named buyer. Most private deals never disclose a consideration, so a dash is the normal case rather than a gap in the record.
| Target | Sector | Sold by | Date | Consideration |
|---|---|---|---|---|
| Lucira | Healthcare & Life Sciences | — | 2023-04-28 | $36m |
| ReViral | Healthcare & Life Sciences | — | 2022-04-07 | $525m |
| Therachon AG | Healthcare & Life Sciences | — | 2019-05-08 | $810m |
| AstraZeneca - Small Molecule Anti-Infective Business | Healthcare & Life Sciences | AstraZeneca | 2016-08-24 | $550m |
Compiled from an archive of 10,204 recorded transactions. This is a record of deals that were reported, not a complete history of what this company has bought, and nothing here is represented as being for sale.
Also buying
Comparable buyers
Other companies acquiring in healthcare & life sciences.
For owners
Own a healthcare & life sciences business?
The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.
Request a confidential valuationFor investors
Are you an investor?
Register your mandate and we will send matching opportunities as they arise.
Register a mandateTargeted buyer search
Which hundred of these would actually buy your business?
A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.